Literature DB >> 20861502

Maxillary ameloblastic fibroma in a dog.

C R Miles1, C M Bell, M E Pinkerton, J W Soukup.   

Abstract

A 4-year-old spayed female Golden Retriever was presented for evaluation of a rostral maxillary gingival mass. An en bloc resection was performed after histologic diagnosis of ameloblastic fibroma from an incisional biopsy specimen. Histologically, the tumor was composed of (1) poorly differentiated vimentin-positive mesenchymal cells that surrounded islands and (2) thin anastomosing trabeculae of odontogenic epithelium that variably coexpressed pancytokeratin and vimentin. To the authors' knowledge, this is the first report of ameloblastic fibroma in a dog. The clinical, radiographic, and histologic findings in this case are compared to those in other domestic animals and humans.
© The Authors 2011

Entities:  

Mesh:

Year:  2010        PMID: 20861502     DOI: 10.1177/0300985810382091

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  4 in total

1.  Locally infiltrative ameloblastic fibroma in a rhesus macaque (Macaca mulatta) with characterizations of its proliferating activity and biological behavior.

Authors:  David X Liu; Lara A Doyle; Mostafa T Bouljihad; Peter J Didier; Margaret H Gilbert; Xiaolei Wang; Bapi Pahar; Rudolf P Bohm; Ronald S Veazey; Andrew A Lackner
Journal:  J Vet Diagn Invest       Date:  2012-05       Impact factor: 1.279

2.  Mixed odontogenic tumors in four young dogs: ameloblastic fibroma and ameloblastic fibro-odontoma.

Authors:  Patrick Huang; Cynthia Bell; Vanessa Wallace; Brian G Murphy
Journal:  J Vet Diagn Invest       Date:  2018-11-18       Impact factor: 1.279

3.  A Mapping Study of Veterinary Literature on Perceptions and Attitudes of Female Canine Spaying.

Authors:  Erik Davis Fausak
Journal:  Front Vet Sci       Date:  2020-12-04

Review 4.  Oncolytic Viruses for Canine Cancer Treatment.

Authors:  Diana Sánchez; Gabriela Cesarman-Maus; Alfredo Amador-Molina; Marcela Lizano
Journal:  Cancers (Basel)       Date:  2018-10-27       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.